Latest Pioglitazone Stories
An increased risk of bladder cancer may not be the only disease risk for people treated with the diabetes drug Actos. Raleigh, NC (PRWEB) March 21, 2014
Last week an Actos trial began in Clark County Courts - Eighth Circuit Court of Nevada where two plaintiffs allege that suffered bladder cancer from Actos.
A new study published in the British Journal of Clinical Pharmacology, recommends prescribers limit pioglitazone (Actos) use to shorter durations due to significantly increased risk of bladder
Another meta-analysis has confirmed an increased risk of bladder cancer among diabetes patients who have taken the drug Actos (pioglitazone). Raleigh, NC (PRWEB)
National network of attorneys continues to provide no-cost consultations over allegations that the use of the diabetes medication Actos can cause bladder cancer. San
Diabetic patients who develop bladder cancer after taking the drug Actos (pioglitazone) tend to have about the same number of Stage I, II, and III cancers as surgical patients who never used Actos.
Research on more than 11,000 Korean users of the diabetes drug pioglitazone finds that smaller doses are no protection against bladder cancer. Raleigh, NC (PRWEB)
Taiwanese author says his research should relieve concern among diabetics that insulin might raise their cancer risk. Raleigh, NC (PRWEB) February 19, 2014
Scientists find a “modest but clinically significant” link between the diabetes drug and bladder cancer. Raleigh, NC (PRWEB) February 17, 2014 The
Researchers say the diabetes drug does not appear to reduce the risk of bladder cancer in patients with type 2 diabetes. Raleigh, NC (PRWEB) February 14, 2014
- An imitative word; an onomatopoetic word.